Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BIOTRONIKS-Safety and Clinical Performance Of the First Drug-Eluting Generation Absorbable Metal Stent In Patients With de Novo Lesions in NatiVE Coronary Arteries (BIOSOLVE - I)
Brief Summary: First in Man Trial with the drug eluting absorbable metal scaffold. To assess safety


Options:
A: Arm Label: Bare metal stent; Type: ACTIVE_COMPARATOR; Interventions: Device: Percutaneous coronary intervention (PCI) | Arm Label: Drug eluting stent; Type: EXPERIMENTAL; Interventions: Device: Percutaneous coronary intervention (PCI) | Intervention Type: DEVICE; Name: Percutaneous coronary intervention (PCI); Assigned to Arm(s): Bare metal stent | Intervention Type: DEVICE; Name: Percutaneous coronary intervention (PCI); Assigned to Arm(s): Drug eluting stent
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: clopidogrel treatment after bare metal stent implantation, Drug: clopidogrel after zotarolimus-eluting stent implantation, Drug: clopidogrel after paclitaxel-eluting stent implantation, Drug: clopidogrel after everolimus-eluting stent implantation | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: clopidogrel treatment after bare metal stent implantation, Drug: clopidogrel after zotarolimus-eluting stent implantation, Drug: clopidogrel after paclitaxel-eluting stent implantation, Drug: clopidogrel after everolimus-eluting stent implantation | Intervention Type: DRUG; Name: clopidogrel treatment after bare metal stent implantation; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: clopidogrel treatment after bare metal stent implantation; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: clopidogrel after zotarolimus-eluting stent implantation; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: clopidogrel after paclitaxel-eluting stent implantation; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: clopidogrel after everolimus-eluting stent implantation; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: clopidogrel after zotarolimus-eluting stent implantation; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: clopidogrel after paclitaxel-eluting stent implantation; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: clopidogrel after everolimus-eluting stent implantation; Assigned to Arm(s): 2
C: Arm Label: Investigational device; Type: EXPERIMENTAL; Interventions: Device: AMS-3.0 | Intervention Type: DEVICE; Name: AMS-3.0; Assigned to Arm(s): Investigational device
D: Arm Label: DES - Zotarolimus Drug eluting stents; Type: ACTIVE_COMPARATOR; Interventions: Device: ENDEAVOR® drug-eluting stent (Medtronic, Santa Rosa, CA), Device: Coronary stent implantation | Arm Label: BMS -Bare metal stent; Type: ACTIVE_COMPARATOR; Interventions: Device: DRIVER bare metal stent (Medtronic, Santa Rosa, Ca), Device: Bare Metal Coronary Stent | Intervention Type: DEVICE; Name: ENDEAVOR® drug-eluting stent (Medtronic, Santa Rosa, CA); Assigned to Arm(s): DES - Zotarolimus Drug eluting stents | Intervention Type: DEVICE; Name: DRIVER bare metal stent (Medtronic, Santa Rosa, Ca); Assigned to Arm(s): BMS -Bare metal stent | Intervention Type: DEVICE; Name: Coronary stent implantation; Assigned to Arm(s): DES - Zotarolimus Drug eluting stents | Intervention Type: DEVICE; Name: Bare Metal Coronary Stent; Assigned to Arm(s): BMS -Bare metal stent

Answer: C